Joseph Theis > Goodwin > Boston, United States > Lawyer Profile
Goodwin Offices
100 NORTHERN AVENUE
BOSTON MA 02210
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Joseph Theis
Position
Partner
Career
Joe Theis, a partner in Goodwin’s Technology Companies and Capital Markets practices, concentrates in general corporate and securities law and has significant experience in capital markets transactions, mergers and acquisitions, venture capital financings, SEC compliance and corporate governance. Mr. Theis represents public and private emerging growth technology and healthcare companies, as well as venture capital funds and investment banks focusing on technology and healthcare companies. He has experience advising companies through every stage of the corporate life cycle – from initial financing through successful initial public offering or acquisition.
Listed in Chambers USA: America’s Leading Lawyers for Business since 2014, Mr. Theis captures attention for his capital markets practice, often featuring significant IPOs. He is viewed as ”very knowledgeable, collaborative and has a solution-oriented approach.”
Education
JD, 2003, Boston College Law School (cum laude) / BA, 2000, Boston College
Lawyer Rankings
United States > Finance > Capital markets: equity offerings
Goodwin‘s broad geographical coverage in the US captures deals from across regions and industries. It remains highly active in biotech and life sciences equity offerings, along with further strength in healthcare, real estate and technology. It also has an extensive client base of investment banks. Although the IPO markets were quiet in 2023, the firm remained active in follow-on offerings, PIPEs, private placements and at-the-market programs. It is best known for mid-cap deals, though does handle bulge-bracket transactions. New York-based Edwin O’Connor is a member of the life sciences group and co-chair of the capital markets practice alongside Silicon Valley’s Bradley Weber. Boston-based Joseph Theis and Robert Puopolo are noted for technology, healthcare and life sciences sector deals.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Industry focus > Cannabis
- Intellectual property > Patents: licensing
- M&A/corporate and commercial > Private equity buyouts: middle-market (Up to $500m)
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
Firm Rankings
- Finance > Capital markets: equity offerings
- Labor and employment > ERISA litigation
- Finance > Fintech
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Real estate > Real estate
- Dispute resolution > Securities litigation: defense
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Finance > Capital markets: debt offerings
- International trade > CFIUS
- M&A/corporate and commercial > Corporate governance
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Financial services litigation
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Tax > US taxes: non-contentious
- Labor and employment > Workplace and employment counseling
- International trade > Customs, export controls and economic sanctions
- Healthcare > Service providers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Intellectual property > Patents: litigation (International Trade Commission)
- M&A/corporate and commercial > Shareholder activism